Model-Integrated Bioequivalence (MIBE) in Generic Drug Research: Can We Ease the Bioequivalence Burden?

Kollipara S, Boddu R, Uppuluri CT, Saini AK

Open source

DOI
10.3390/pharmaceutics18050536
Published
2026 Apr 28
Container
Pharmaceutics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics18050536,
  title = {Model-Integrated Bioequivalence (MIBE) in Generic Drug Research: Can We Ease the Bioequivalence Burden?},
  author = {Kollipara S and Boddu R and Uppuluri CT and Saini AK},
  year = {2026},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics18050536},
  url = {https://doi.org/10.3390/pharmaceutics18050536}
}

RIS

TY  - JOUR
TI  - Model-Integrated Bioequivalence (MIBE) in Generic Drug Research: Can We Ease the Bioequivalence Burden?
AU  - Kollipara S
AU  - Boddu R
AU  - Uppuluri CT
AU  - Saini AK
PY  - 2026
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics18050536
UR  - https://doi.org/10.3390/pharmaceutics18050536
ER  - 

APA

S, K., R, B., CT, U., & AK, S. (2026). Model-Integrated Bioequivalence (MIBE) in Generic Drug Research: Can We Ease the Bioequivalence Burden?. Pharmaceutics. https://doi.org/10.3390/pharmaceutics18050536

Source records